Literature DB >> 1648961

Thrombin-induced effects are selectively inhibited following treatment of intact human platelets with okadaic acid.

K M Lerea1.   

Abstract

The involvement of protein phosphatases in regulating platelet activation was studied. The major portion of the phosphorylase phosphatase activity found in platelet lysates appears to be of the type 1 variety. The identification of this enzyme was based on the finding that greater than 80% of protein phosphatase activity was inhibited by the heat-stable inhibitor protein inhibitor 2 and, while only 20% of the phosphorylase phosphatase activity in platelet extracts was inhibited by 2 nM okadaic acid, greater than 95% of the activity was inhibited in the presence of 1 microM okadaic acid. Increases in protein phosphorylations occurred and thrombin-induced release of serotonin was prevented as a result of artificially inhibiting the enzyme with okadaic acid in intact platelets. This implies either that the regulation of okadaic acid sensitive protein phosphatases is necessary for some agonist-induced effects or that okadaic acid sensitive phosphatases are required for maintaining platelets in a responsive state.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648961     DOI: 10.1021/bi00242a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Relocation of annexin V to platelet membranes is a phosphorylation-dependent process.

Authors:  P J Trotter; M A Orchard; J H Walker
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

2.  Identification and localization of myosin phosphatase in human platelets.

Authors:  A Murányi; F Erdodi; M Ito; P Gergely; D J Hartshorne
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

3.  Aggregation-dependent, integrin-mediated increases in cytoskeletally associated PtdInsP2 (4,5) levels in human platelets are controlled by translocation of PtdIns 4-P 5-kinase C to the cytoskeleton.

Authors:  K A Hinchliffe; R F Irvine; N Divecha
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

4.  Dephosphorylation of cofilin in stimulated platelets: roles for a GTP-binding protein and Ca2+.

Authors:  M M Davidson; R J Haslam
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

5.  Role of type 1 and type 2A phosphatases in signal transduction of platelet-activating-factor-stimulated rabbit platelets.

Authors:  C T Murphy; J Westwick
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

6.  Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.

Authors:  M A Packham; A A Livne; D H Ruben; M L Rand
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

7.  Cytoskeletal reorganization of human platelets induced by the protein phosphatase 1/2 A inhibitors okadaic acid and calyculin A.

Authors:  Y Yano; M Sakon; J Kambayashi; T Kawasaki; T Senda; K Tanaka; F Yamada; N Shibata
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

8.  Dissociation of SHP-1 from spinophilin during platelet activation exposes an inhibitory binding site for protein phosphatase-1 (PP1).

Authors:  Peisong Ma; Darci C Foote; Andrew J Sinnamon; Lawrence F Brass
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.